These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26677859)

  • 1. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
    Thakkar HP; Pancholi N; Patel CV
    AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled porosity solubility modulated osmotic pump tablets of gliclazide.
    Banerjee A; Verma PR; Gore S
    AAPS PharmSciTech; 2015 Jun; 16(3):554-68. PubMed ID: 25378281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and
    Ma C; Huang Z; Zhu Y; Chen X; Singh V; Huang Y; Pan X; Wu C
    Pharmazie; 2017 Sep; 72(9):511-517. PubMed ID: 29441977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.
    Adibkia K; Ghanbarzadeh S; Shokri MH; Arami Z; Arash Z; Shokri J
    Pharm Dev Technol; 2014 Jun; 19(4):507-12. PubMed ID: 23763379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled porosity osmotic pump system for the delivery of diclofenac sodium: in-vitro and in-vivo evaluation.
    Emara LH; Taha NF; El-Ashmawy AA; Raslan HM; Mursi NM
    Pharm Dev Technol; 2014 Sep; 19(6):681-91. PubMed ID: 24320694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
    Song QL; Li P; Li YM
    Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
    Cheng X; Sun M; Gao Y; Cao F; Zhai G
    Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.
    Shokri J; H Zarrintan M; Ghanbarzadeh S; Arash Z; Farahani A; Adibkia K
    Drug Res (Stuttg); 2013 Aug; 63(8):414-9. PubMed ID: 23599037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of prazosin hydrochloride from osmotic pump system prepared by coating the core tablet with an indentation.
    Liu L; Wang J; Zhu S
    Drug Deliv; 2007 Apr; 14(4):219-24. PubMed ID: 17497354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
    Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
    Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The delivery mechanism of micro-porous osmotic pump tablets].
    Zhao XL; Li Q; Gong XF; Li SM
    Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled porosity osmotic pumps of highly aqueous soluble drug containing hydrophilic polymers as release retardants.
    Prabakaran D; Singh P; Kanaujia P; Mishra V; Jaganathan KS; Vyas SP
    Pharm Dev Technol; 2004 Nov; 9(4):435-42. PubMed ID: 15581079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
    Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
    Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
    Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
    AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of controlled porosity osmotic tablet of diltiazem hydrochloride.
    Shahi SR; Zadbuke NS; Gulecha B; Shivanikar SS; Shinde SB
    J Adv Pharm Technol Res; 2012 Oct; 3(4):229-36. PubMed ID: 23378944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Push-Pull Controlled Drug Release Systems: Effect of Molecular Weight of Polyethylene Oxide on Drug Release.
    Nakajima T; Takeuchi I; Ohshima H; Terada H; Makino K
    J Pharm Sci; 2018 Jul; 107(7):1896-1902. PubMed ID: 29548974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.